Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC

NCT04322578 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Crizotinib
DRUG: Pemetrexed

Sponsor

Hunan Province Tumor Hospital